The size of the Asia Pacific Enteral Feeding Devices Market was worth USD 0.58 billion in 2022 and is estimated to be growing at a CAGR of 5.35% to reach USD 0.75 billion by 2027. The growing number of pre-term births, the rising number of older people, and the increasing enteral nutrition consciousness drive the Asia Pacific market. According to WHO, an estimated 3.5 million pre-term births were registered in India from January 2014 to November 2015.
Factors such as growing demand from the home care sector, the prevalence of chronic diseases, the incidence of pre-term birth, and the growing geriatric population drive the enteral feeding devices market in the Asia-Pacific region. The high number of malnutrition patients and those unable to take nutrients orally worldwide is one of the significant factors propelling the market growth. In addition, the rising geriatric population suffering from neurological conditions such as multiple sclerosis, stroke, and dementia that impact swallowing, is the most significant target population. Thus, nutritional support in oral nutrition supplements and enteral nutrition feeding tube support mitigates the challenges of nutrition deficits among these diagnosed populations. Furthermore, the high prevalence of premature births, especially in developing economies such as China and India, is among the key factors driving the enteral feeding devices market. Furthermore, the enteral feeding devices market in APAC is strongly driven by technological advancements that improve dense and small, lightweight enteral feeding pumps manufactured using durable materials.
Reimbursement policies are available for enteral feeding therapy in developed countries such as the US, Canada, France, Germany, the UK, and Japan. However, such provisions are not present in developing countries across the Asia Pacific, Latin America, and the Middle East, which is a significant factor hampering the growth of the enteral feeding devices market in the Asia-Pacific region. In addition, many countries in APAC still lack research and development of enteral feeding therapy and devices.
This research report on the APAC Enteral Feeding Devices Market has been segmented and sub-segmented into the following categories:
By Product Type:
By End User:
Regionally, the Asia-Pacific enteral feeding devices market is expected to record the highest CAGR among all the regions during the forecast period due to the new market potential. China is the largest market for Enteral Feeding Devices in this region. In addition, India is also a potential target for Enteral Feeding device manufacturers due to its high propensity for chronic diseases such as diabetes and cancer.
The growing number of hospitals and healthcare infrastructure has helped the Asia Pacific emerge as a significant investment hub and dynamically attract lucrative investment opportunities. The rapid rise in the geriatric population and increasing nutritional deficiency problems have favored the region's growth. About 190.7 million people suffer from malnutrition in India. More than 53% of deaths occur due to chronic disease, suggesting a rise in enteral feeding therapy and devices across homecare services and hospitals. Attributable to these regional trends, reports claim that India's enteral feeding devices market is poised to record a CAGR of 7.1% from 2020 to 2025.
KEY MARKET PLAYERS:
A few of the leading players in the APAC enteral feeding devices market profiled in this report are Halyard Health Inc., C. R. Bard Inc., Abbott Laboratories, Fresenius SE, Covidien PLC, Cook Medical, and Nestle S.A.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org